IL-27R signaling, therefore, was found to have an essential immunoregulatory role, reducing expression of myeloid- (Fig. 4A–D) and T cell-derived cytokines (Fig. 6) both in early and in advanced stages of atherosclerosis. The gene discussed is IL27RA; the disease is atherosclerosis.